<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18093/0869-0189-2021-31-3-355-363</article-id><article-id custom-type="elpub" pub-id-type="custom">pulmo-2372</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL PHARMACOLOGY</subject></subj-group></article-categories><title-group><article-title>О перспективах применения тиамина, пиридоксина и цианокобаламина в комплексной терапии и реабилитации пациентов с COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>On the prospects for the use of thiamine, pyridoxine, and cyanocobalamin in the complex therapy and rehabilitation of patients with COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна – д. м. н., профессор, ведущий научный сотрудник Института фармакоинформатики при Федеральном исследовательском центре «Информатика и управление» Российской академии наук; ведущий научный сотрудник отдела интеллектуальных систем Центра технологий хранения и анализа больших данных на базе Федерального государственного бюджетного образовательного учреждения высшего образования «Московский государственный университет имени М.В.Ломоносова». SPIN: 6317-9833, Author ID: 94901, Author ID: 7003589812, WOS ID: J-4946-2017</p><p>119333, Москва, ул. Вавилова, 44, корп. 2119234, Москва, Ленинские горы, 1тел.: (916) 108-09-03</p></bio><bio xml:lang="en"><p>Olga A. Gromova, Doctor of Medicine, Professor, Leading Researcher, Institute of Pharmacoinformatics, Federal Research Center “Informatics and Control”, Russian Academy of Sciences; Leading Researcher, Department of Intelligent Systems, Center for storing and analyzing big data, National Center for Digital Economy, Moscow State University M.V.Lomonosov. SPIN: 6317-9833, Author ID: 94901, Author ID: 7003589812, WOS ID: J-4946-2017</p><p>ul. Vavilova 44, build. 2, Moscow, 119333Leninskie Gory 1, Moscow, 119991tel.: (916) 108-09-03</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич – к. ф.-м. н., к. х. н., старший научный сотрудник отдела интеллектуальных систем Института фармакоинформатики при Федеральном исследовательском центре «Информатика и управление» Российской академии наук; научный руководитель Центра технологий хранения и анализа больших данных на базе Федерального государственного бюджетного образовательного учреждения высшего образования «Московский государственный университет имени М.В.Ломоносова». Author ID: 7003300274, SPIN-код: 1375-1114, Author ID: 54104, WOS ID: C-7683-2018</p><p>119333, Москва, ул. Вавилова, 44, корп. 2119234, Москва, Ленинские горы, 1тел.: (499) 135-24-89</p></bio><bio xml:lang="en"><p>Ivan Yu. Torshin, Candidate of Physics &amp; Mathematics, Candidate of Chemistry, Senior Researcher, Department of Intellectual Systems, Institute of Pharmacoinformatics, Federal Research Center “Informatics and Control”, Russian Academy of Sciences, Academic Advisor, Center for storing and analyzing big data, National Center for Digital Economy, Moscow State University M.V.Lomonosov. Author ID: 7003300274, SPIN: 1375-1114, Author ID: 54104, WOS ID: C-7683-2018</p><p>ul. Vavilova 44, build. 2, Moscow, 119333Leninskie Gory 1, Moscow, 119991tel.: (499) 135-24-89</p></bio><email xlink:type="simple">tiy135@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5070-5450</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чучалин</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuchalin</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чучалин Александр Григорьевич – д. м. н., профессор, академик Российской академии наук, заведующий кафедрой госпитальной терапии педиатрического факультета</p><p>117997, Москва, ул. Островитянова, 1тел.: (499) 780-08-50</p></bio><bio xml:lang="en"><p>Alexander G. Chuchalin, Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, Head of Department of Hospital Internal Medicine, Pediatric Faculty</p><p>ul. Ostrovityanova 1, Moscow, 117997tel.: (499) 780-08-50</p></bio><email xlink:type="simple">pulmomoskva@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт фармакоинформатики при Федеральном исследовательском центре «Информатика и управление» Российской академии наук; Центр технологий хранения и анализа больших данных на базе Федерального государственного бюджетного образовательного учреждения высшего образования «Московский государственный университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Pharmacoinformatics, Federal Research Center “Informatics and Control”, Russian Academy of Sciences; Center for storing and analyzing big data, National Center for Digital Economy, Moscow State University M.V. Lomonosov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University (Pirogov Medical University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>10</day><month>06</month><year>2021</year></pub-date><volume>31</volume><issue>3</issue><fpage>355</fpage><lpage>363</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Громова О.А., Торшин И.Ю., Чучалин А.Г., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Громова О.А., Торшин И.Ю., Чучалин А.Г.</copyright-holder><copyright-holder xml:lang="en">Gromova O.A., Torshin I.Y., Chuchalin A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/2372">https://journal.pulmonology.ru/pulm/article/view/2372</self-uri><abstract><p>Важность постоянной поддержки систем врожденного противовирусного иммунитета обусловлена в т. ч. новой коронавирусной инфекцией COVID-19. Целью исследования явился систематический анализ публикаций, посвященных исследованиям применения витаминов группы В для поддержки иммунитета и реабилитации пациентов с COVID-19. Материалы и методы. Выполнен интеллектуальный анализ сверхбольших данных (big data) при помощи специальных вычислительных методов анализа «больших данных» биомедицинских публикаций, основанных на топологической теории сентимент-анализа медицинских текстов, индексируемых базами данных PubMed / MEDLINE. Результаты. Низкая обеспеченность витаминами группы В способствует формированию у пациента хронических коморбидных патологий и существенно отягощает клиническое течение COVID-19. Важность повышения обеспеченности витаминами группы В при COVID-19 обусловлена поддержанием энергетического и кислородного метаболизма, прямыми противовирусными эффектами витаминов (снижение репликации SARS-CoV-2), компенсацией хронических коморбидных патологий (тромбоэмболия, нарушения функции печени и почек, сахарный диабет (СД), полинейропатии)), отягощающих течение COVID-19; снижением гипергомоцистеинемии и хронического асептического воспаления; ингибированием карбоангидраз, при котором улучшается кислородный обмен в легких; увеличением клиренса лактата крови и профилактикой сепсиса. Заключение. Посредством улучшения миелинизации обонятельных сенсорных нейронов витамин В12 способствует преодолению аносмии, которая встречается у 80 % пациентов с COVID-19. Короткие курсы (до 2–3 нед.) высокодозной парентеральной терапии тиамином, пиридоксином и цианокобаламином могут быть использованы в комплексе терапевтических мероприятий для улучшения клинических исходов у пациентов с COVID-19, особенно пожилых, лиц с полигиповитаминозом, СД, гипергомоцистеинемией, тромбофилией и высоким риском развития сепсиса. Пероральная терапия тиамином, пиридоксином и цианокобаламином рациональна в рамках проведения реабилитационных мероприятий у лиц, уже перенесших COVID-19 и столкнувшихся с его последствиями в виде клинических признаков недостатка витаминов группы В.</p></abstract><trans-abstract xml:lang="en"><p>The new coronavirus infection COVID-19 has highlighted the importance of ongoing support for innate antiviral immunity systems. The aim. Conduct a systematic review of publications on the research of the use of B vitamins to support immunity and rehabilitation of patients with COVID-19. Methods. Intelligent analysis of so-called Big Data and special computational methods for analyzing Big Data of biomedical publications, based on the topological theory of sentiment analysis of medical texts from PubMed/MEDLINE. Results. Low levels of B vitamins contribute to chronic comorbidities and aggravate the clinical course of COVID-19 significantly. Increasing the supply of B vitamins in COVID-19 patients is essential for the maintenance of energy and oxygen metabolism; the direct antiviral effects of vitamins (reduction of SARS-CoV-2 replication); compensation of chronic comorbidities (thromboembolism, impaired liver and kidney functions, diabetes mellitus, polyneuropathy), which aggravate the course of COVID-19; reducing hyperhomocysteinemia and chronic aseptic inflammation; inhibiting carbonic anhydrases to improve oxygen metabolism in the lungs, and increasing the clearance of lactate from the blood and preventing sepsis. Conclusion. By improving myelination of the olfactory sensory neurons, vitamin B12 can help overcome anosmia, which occurs in 80% of COVID-19 patients. Short courses (up to 2 – 3 weeks) of high-dose parenteral therapy with thiamine, pyridoxine, and cyanocobalamin can be used as a part of a complex of therapeutic measures to improve clinical outcomes in patients with COVID-19, especially in elderly patients with polyhypovitaminosis, diabetes mellitus, hyperhomocysteinemia, thrombophilia, and high risk of sepsis. Oral therapy with thiamine, pyridoxine, and cyanocobalamin is justified as a part of rehabilitation measures after COVID-19 in patients who have faced its consequences in the form of clinical signs of vitamin B vitamin deficiency.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>кислородный обмен</kwd><kwd>коронавирусная пневмония</kwd><kwd>микронутриенты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>oxygen metabolis</kwd><kwd>coronavirus pneumonia</kwd><kwd>micronutrients</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена за счет гранта Российского научного фонда (проект № 20-12-00175).</funding-statement><funding-statement xml:lang="en">The article was financially supported by the grant of the Russian Science Foundation (project No.20-12-00175).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Calder P.C., Carr A.C., Gombart A.F., Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020; 12 (4): 1181. DOI: 10.3390/nu12041181.</mixed-citation><mixed-citation xml:lang="en">Calder P.C., Carr A.C., Gombart A.F., Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020; 12 (4): 1181. DOI: 10.3390/nu12041181.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Гусев Е.И. Синергидные нейропротекторные эффекты тиамина, пиридоксина и цианокобаламина в рамках протеома человека. Фармакокинетика и фармакодинамика. 2017; (1): 40–51. Доступно на: https://www.pharmacokinetica.ru/jour/article/view/7/7</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Gusev E.I. [Synergistic neuroprotective effects of thiamine, pyridoxine and cyanocobalamin on the level of human proteome]. Pharmacokinetics and рharmacodynamics. 2017; (1): 40–51. Available at: https://www.pharmacokinetica.ru/jour/article/view/7/7 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shakoor H., Feehan J., Mikkelsen K. et al. Be well: A potential role for vitamin B in COVID-19. Maturitas. 2021; 144: 108–111. DOI: 10.1016/j.maturitas.2020.08.007.</mixed-citation><mixed-citation xml:lang="en">Shakoor H., Feehan J., Mikkelsen K. et al. Be well: A potential role for vitamin B in COVID-19. Maturitas. 2021; 144: 108–111. DOI: 10.1016/j.maturitas.2020.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hamer D.H., Sempertegui F., Estrella B. et al. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J. Nutr. 2009; 139 (1): 113–119. DOI: 10.3945/jn.108.095091.</mixed-citation><mixed-citation xml:lang="en">Hamer D.H., Sempertegui F., Estrella B. et al. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J. Nutr. 2009; 139 (1): 113–119. DOI: 10.3945/jn.108.095091.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Thaller G. [Vitamin B 12 in the prevention of influenza]. Munch Med. Wochenschr. 1957; 99 (52): 1977–1978 (in German).</mixed-citation><mixed-citation xml:lang="en">Thaller G. [Vitamin B 12 in the prevention of influenza]. Munch Med. Wochenschr. 1957; 99 (52): 1977–1978 (in German).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Axelrod A.E., Hopper S. Effects of pantothenic acid, pyridoxine and thiamine deficiencies upon antibody formation to influenza virus PR-8 in rats. J. Nutr. 1960; 72 (3): 325–330. DOI: 10.1093/jn/72.3.325.</mixed-citation><mixed-citation xml:lang="en">Axelrod A.E., Hopper S. Effects of pantothenic acid, pyridoxine and thiamine deficiencies upon antibody formation to influenza virus PR-8 in rats. J. Nutr. 1960; 72 (3): 325–330. DOI: 10.1093/jn/72.3.325.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chang H.Y., Tang F.Y., Chen D.Y. et al. Clinical use of cyclooxygenase inhibitors impairs vitamin B-6 metabolism. Am. J. Clin. Nutr. 2013; 98 (6): 1440–1449. DOI: 10.3945/ajcn.113.064477.</mixed-citation><mixed-citation xml:lang="en">Chang H.Y., Tang F.Y., Chen D.Y. et al. Clinical use of cyclooxygenase inhibitors impairs vitamin B-6 metabolism. Am. J. Clin. Nutr. 2013; 98 (6): 1440–1449. DOI: 10.3945/ajcn.113.064477.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Ребров В.Г. Витамины, макро- и микроэлементы. Обучающие программы РСЦ института микроэлементов ЮНЕСКО. М.: ГЭОТАР-Медиа, 2008.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Rebrov V.G. [Vitamins, macro- and microelements. Educational programs of the RSC of the UNESCO Institute of Microelements]. Moscow: GEOTAR-Media; 2008 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Шаповалова Ю.О. и др. COVID-19 и железодефицитная анемия: взаимосвязи патогенеза и терапии. Акушерство, гинекология и репродукция. 2020;14 (5): 654–665. DOI: 10.17749/2313-7347/ob.gyn.rep.2020.179</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Shapovalova Yu.O. et al. [COVID-19 and iron deficiency anemia: relationships of pathogenesis and therapy]. Akusherstvo, ginekologiya i reproduktsiya. 2020; 14 (5): 654–665. DOI: 10.17749/2313-7347/ob.gyn.rep.2020.179 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maiorova L.A., Erokhina S.I., Pisani M. et al. Encapsulation of vitamin B 12 into nanoengineered capsules and soft matter nanosystems for targeted delivery. Colloids Surf. B Biointerfaces. 2019; 182: 110366. DOI: 10.1016/j.colsurfb.2019.110366.</mixed-citation><mixed-citation xml:lang="en">Maiorova L.A., Erokhina S.I., Pisani M. et al. Encapsulation of vitamin B 12 into nanoengineered capsules and soft matter nanosystems for targeted delivery. Colloids Surf. B Biointerfaces. 2019; 182: 110366. DOI: 10.1016/j.colsurfb.2019.110366.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Narayanan N., Nair D.T. Vitamin B 12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life. 2020; 72 (10): 2112–2120. DOI: 10.1002/iub.2359.</mixed-citation><mixed-citation xml:lang="en">Narayanan N., Nair D.T. Vitamin B 12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life. 2020; 72 (10): 2112–2120. DOI: 10.1002/iub.2359.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Barbieri A., Robinson N., Palma G. et al. Can beta-2-adrenergic pathway be a new target to combat SARS-CoV-2 hyperinflammatory syndrome? – Lessons learned from cancer. Front. Immunol. 2020; 11: 588724. DOI: 10.3389/fimmu.2020.588724.</mixed-citation><mixed-citation xml:lang="en">Barbieri A., Robinson N., Palma G. et al. Can beta-2-adrenergic pathway be a new target to combat SARS-CoV-2 hyperinflammatory syndrome? – Lessons learned from cancer. Front. Immunol. 2020; 11: 588724. DOI: 10.3389/fimmu.2020.588724.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vatsalya V., Li F., Frimodig J.C. et al. Therapeutic prospects for Th-17 cell immune storm syndrome and neurological symptoms in COVID-19: thiamine efficacy and safety, in-vitro evidence and pharmacokinetic profile. medRxiv. 2020: 2020.08.23.20177501 [Preprint. Posted: August 25, 2020]. DOI: 10.1101/2020.08.23.20177501.</mixed-citation><mixed-citation xml:lang="en">Vatsalya V., Li F., Frimodig J.C. et al. Therapeutic prospects for Th-17 cell immune storm syndrome and neurological symptoms in COVID-19: thiamine efficacy and safety, in-vitro evidence and pharmacokinetic profile. medRxiv. 2020: 2020.08.23.20177501 [Preprint. Posted: August 25, 2020]. DOI: 10.1101/2020.08.23.20177501.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А. Микронутриенты против коронавирусов. Под ред. А.Г.Чучалина. М.: ГЭОТАР-Медиа; 2020.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Gromova O.A. [Micronutrients against coronaviruses]. Chuchalin A.G. (ed.). Moscow: GEOTAR-Media; 2020 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Uckun F.M., Carlson J., Orhan C. et al. Rejuveinix shows a favorable clinical safety profile in human subjects and exhibits potent preclinical protective activity in the lipopolysaccharide-galactosamine mouse model of acute respiratory distress syndrome and multi-organ failure. Front. Pharmacol. 2020; 11: 594321. DOI: 10.3389/fphar.2020.594321.</mixed-citation><mixed-citation xml:lang="en">Uckun F.M., Carlson J., Orhan C. et al. Rejuveinix shows a favorable clinical safety profile in human subjects and exhibits potent preclinical protective activity in the lipopolysaccharide-galactosamine mouse model of acute respiratory distress syndrome and multi-organ failure. Front. Pharmacol. 2020; 11: 594321. DOI: 10.3389/fphar.2020.594321.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Procter B.C., Ross C., Pickard V. et al. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection. Rev. Cardiovasc. Med. 2020; 21 (4): 611–614. DOI: 10.31083/j.rcm.2020.04.260.</mixed-citation><mixed-citation xml:lang="en">Procter B.C., Ross C., Pickard V. et al. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection. Rev. Cardiovasc. Med. 2020; 21 (4): 611–614. DOI: 10.31083/j.rcm.2020.04.260.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tan C.W., Ho L.P., Kalimuddin S. et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B 12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020; 79–80: 111017. DOI: 10.1016/j.nut.2020.111017.</mixed-citation><mixed-citation xml:lang="en">Tan C.W., Ho L.P., Kalimuddin S. et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B 12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020; 79–80: 111017. DOI: 10.1016/j.nut.2020.111017.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Лисицына Е.Ю. Гепатопротекторные свойства витаминов в преконцепции и при беременности. Земский врач. 2011; (4): 23–28. Доступно на: https://cyberleninka.ru/article/n/gepatoprotektornye-svoystva-vitaminov-v-prekontseptsii-i-pri-beremennosti/viewer</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Lisitsyna E.Yu. [Hepatoprotective properties of vitamins in preconception and during pregnancy]. Zemskiy vrach. 2011; (4): 23–28. Available at: https://cyberleninka.ru/article/n/gepatoprotektornye-svoystva-vitaminov-v-prekontseptsii-i-pri-beremennosti/viewer (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez-Vazquez A.J., Garcia-Sanchez J.A., Moreno-Arriola E. et al. Thiamine deprivation produces a liver ATP deficit and metabolic and genomic effects in mice: Findings are parallel to those of biotin deficiency and have implications for energy disorders. J. Nutrigenet. Nutrigenomics. 2016; 9 (5-6): 287–299. DOI: 10.1159/000456663.</mixed-citation><mixed-citation xml:lang="en">Hernandez-Vazquez A.J., Garcia-Sanchez J.A., Moreno-Arriola E. et al. Thiamine deprivation produces a liver ATP deficit and metabolic and genomic effects in mice: Findings are parallel to those of biotin deficiency and have implications for energy disorders. J. Nutrigenet. Nutrigenomics. 2016; 9 (5-6): 287–299. DOI: 10.1159/000456663.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Levy S., Herve C., Delacoux E., Erlinger S. Thiamine deficiency in hepatitis C virus and alcohol-related liver diseases. Dig. Dis. Sci. 2002; 47 (3): 543–548. DOI: 10.1023/a:1017907817423.</mixed-citation><mixed-citation xml:lang="en">Levy S., Herve C., Delacoux E., Erlinger S. Thiamine deficiency in hepatitis C virus and alcohol-related liver diseases. Dig. Dis. Sci. 2002; 47 (3): 543–548. DOI: 10.1023/a:1017907817423.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Butterworth R.F. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab. Brain. Dis. 2009; 24 (1): 189–196. DOI: 10.1007/s11011-008-9129-y.</mixed-citation><mixed-citation xml:lang="en">Butterworth R.F. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab. Brain. Dis. 2009; 24 (1): 189–196. DOI: 10.1007/s11011-008-9129-y.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C., Liang J., Zhang C. et al. Effect of ascorbic Acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann. Occup. Hyg. 2007; 51 (6): 563–569. DOI: 10.1093/annhyg/mem036.</mixed-citation><mixed-citation xml:lang="en">Wang C., Liang J., Zhang C. et al. Effect of ascorbic Acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann. Occup. Hyg. 2007; 51 (6): 563–569. DOI: 10.1093/annhyg/mem036.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao M., Ralat M.A., da Silva V. et al. Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells. Am. J. Physiol. Endocrinol. Metab. 2013; 304 (4): e342–351. DOI: 10.1152/ajpendo.00359.2012.</mixed-citation><mixed-citation xml:lang="en">Zhao M., Ralat M.A., da Silva V. et al. Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells. Am. J. Physiol. Endocrinol. Metab. 2013; 304 (4): e342–351. DOI: 10.1152/ajpendo.00359.2012.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng C.P., Chen C.H., Kuo C.S. et al. Dietary choline and folate relationships with serum hepatic inflammatory injury markers in Taiwanese adults. Asia Pac. J. Clin. Nutr. 2017; 26 (4): 642–649. DOI: 10.6133/apjcn.082016.03.</mixed-citation><mixed-citation xml:lang="en">Cheng C.P., Chen C.H., Kuo C.S. et al. Dietary choline and folate relationships with serum hepatic inflammatory injury markers in Taiwanese adults. Asia Pac. J. Clin. Nutr. 2017; 26 (4): 642–649. DOI: 10.6133/apjcn.082016.03.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hirsch S., Poniachick J., Avendano M. et al. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition. 2005; 21 (2): 137–141. DOI: 10.1016/j.nut.2004.03.022.</mixed-citation><mixed-citation xml:lang="en">Hirsch S., Poniachick J., Avendano M. et al. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition. 2005; 21 (2): 137–141. DOI: 10.1016/j.nut.2004.03.022.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Harb Z., Deckert V., Bressenot A.M. et al. The deficit in folate and vitamin B 12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis. J. Nutr. Biochem. 2020; 84: 108415. DOI: 10.1016/j.jnutbio.2020.108415.</mixed-citation><mixed-citation xml:lang="en">Harb Z., Deckert V., Bressenot A.M. et al. The deficit in folate and vitamin B 12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis. J. Nutr. Biochem. 2020; 84: 108415. DOI: 10.1016/j.jnutbio.2020.108415.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Veber D., Mutti E., Tacchini L. et al. Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. J. Neurosci. Res. 2008; 86 (6): 1380–1387. DOI: 10.1002/jnr.21599.</mixed-citation><mixed-citation xml:lang="en">Veber D., Mutti E., Tacchini L. et al. Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. J. Neurosci. Res. 2008; 86 (6): 1380–1387. DOI: 10.1002/jnr.21599.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Isoda K., Kagaya N., Akamatsu S. et al. Hepatoprotective effect of vitamin B 12 on dimethylnitrosamine-induced liver injury. Biol. Pharm. Bull. 2008; 31 (2): 309–311. DOI: 10.1248/bpb.31.309.</mixed-citation><mixed-citation xml:lang="en">Isoda K., Kagaya N., Akamatsu S. et al. Hepatoprotective effect of vitamin B 12 on dimethylnitrosamine-induced liver injury. Biol. Pharm. Bull. 2008; 31 (2): 309–311. DOI: 10.1248/bpb.31.309.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xia M.F., Bian H., Zhu X.P. et al. Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. Clin. Nutr. 2018; 37 (5): 1752–1758. DOI: 10.1016/j.clnu.2017.06.021.</mixed-citation><mixed-citation xml:lang="en">Xia M.F., Bian H., Zhu X.P. et al. Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. Clin. Nutr. 2018; 37 (5): 1752–1758. DOI: 10.1016/j.clnu.2017.06.021.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Koplay M., Gulcan E., Ozkan F. Association between serum vitamin B 12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease. J. Investig. Med. 2011; 59 (7): 1137–1140. DOI: 10.2310/JIM.0b013e31822a29f5.</mixed-citation><mixed-citation xml:lang="en">Koplay M., Gulcan E., Ozkan F. Association between serum vitamin B 12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease. J. Investig. Med. 2011; 59 (7): 1137–1140. DOI: 10.2310/JIM.0b013e31822a29f5.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">van Kempen T.A.T.G., Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19. Am. J. Physiol. Endocrinol. Metab. 2021; 320 (1): e2–6. DOI: 10.1152/ajpendo.00474.2020.</mixed-citation><mixed-citation xml:lang="en">van Kempen T.A.T.G., Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19. Am. J. Physiol. Endocrinol. Metab. 2021; 320 (1): e2–6. DOI: 10.1152/ajpendo.00474.2020.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sato K., Morofuji Y., Horie N. et al. Hyperhomocysteinemia causes severe intraoperative thrombotic tendency in superficial temporal artery-middle cerebral artery bypass. J. Stroke Cerebrovasc. Dis. 2020; 29 (5): 104633. DOI: 10.1016/j.jstrokecerebrovasdis.2019.104633.</mixed-citation><mixed-citation xml:lang="en">Sato K., Morofuji Y., Horie N. et al. Hyperhomocysteinemia causes severe intraoperative thrombotic tendency in superficial temporal artery-middle cerebral artery bypass. J. Stroke Cerebrovasc. Dis. 2020; 29 (5): 104633. DOI: 10.1016/j.jstrokecerebrovasdis.2019.104633.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou K., Zhao R., Geng Z. et al. Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies. J. Thromb. Thrombolysis. 2012; 34 (4): 459–467. DOI: 10.1007/s11239-012-0759-x.</mixed-citation><mixed-citation xml:lang="en">Zhou K., Zhao R., Geng Z. et al. Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies. J. Thromb. Thrombolysis. 2012; 34 (4): 459–467. DOI: 10.1007/s11239-012-0759-x.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Taheraghdam A.A., Dalirakbari N., Khalili M. et al. Hyperhomocysteinemia, low vitamin B12, and low folic acid: Are risk factors of cerebral vascular thrombosis in northwest Iran? J. Res. Med. Sci. 2016; 21: 16. DOI: 10.4103/1735-1995.178755.</mixed-citation><mixed-citation xml:lang="en">Taheraghdam A.A., Dalirakbari N., Khalili M. et al. Hyperhomocysteinemia, low vitamin B12, and low folic acid: Are risk factors of cerebral vascular thrombosis in northwest Iran? J. Res. Med. Sci. 2016; 21: 16. DOI: 10.4103/1735-1995.178755.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kotwal J., Kotwal A., Bhalla S. et al. Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial. Thromb. Res. 2015; 136 (4): 758–762. DOI: 10.1016/j.thromres.2015.08.001.</mixed-citation><mixed-citation xml:lang="en">Kotwal J., Kotwal A., Bhalla S. et al. Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial. Thromb. Res. 2015; 136 (4): 758–762. DOI: 10.1016/j.thromres.2015.08.001.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira E.N.G.D.S., Silvares R.R., Flores E.E.I. et al. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease. Microcirculation. 2020; 27 (3): e12603. DOI: 10.1111/micc.12603.</mixed-citation><mixed-citation xml:lang="en">Pereira E.N.G.D.S., Silvares R.R., Flores E.E.I. et al. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease. Microcirculation. 2020; 27 (3): e12603. DOI: 10.1111/micc.12603.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Vučković B.A., van Rein N., Cannegieter S.C. et al. Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study. Am. J. Clin. Nutr. 2015; 101 (3): 606–612. DOI: 10.3945/ajcn.114.095398.</mixed-citation><mixed-citation xml:lang="en">Vučković B.A., van Rein N., Cannegieter S.C. et al. Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study. Am. J. Clin. Nutr. 2015; 101 (3): 606–612. DOI: 10.3945/ajcn.114.095398.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Baghizadeh Fini M. Oral saliva and COVID-19. Oral Oncol. 2020; 108: 104821. DOI: 10.1016/j.oraloncology.2020.104821.</mixed-citation><mixed-citation xml:lang="en">Baghizadeh Fini M. Oral saliva and COVID-19. Oral Oncol. 2020; 108: 104821. DOI: 10.1016/j.oraloncology.2020.104821.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wee A.K.H. COVID-19's toll on the elderly and those with diabetes mellitus – Is vitamin B 12 deficiency an accomplice? Med. Hypotheses. 2021; 146: 110374. DOI: 10.1016/j.mehy.2020.110374.</mixed-citation><mixed-citation xml:lang="en">Wee A.K.H. COVID-19's toll on the elderly and those with diabetes mellitus – Is vitamin B 12 deficiency an accomplice? Med. Hypotheses. 2021; 146: 110374. DOI: 10.1016/j.mehy.2020.110374.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Gonçalves S.E.A.B., Gonçalves T.J.M., Guarnieri A. et al. Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS-CoV-2. J. Diabetes. 2021; 13 (5): 413–419. DOI: 10.1111/1753-0407.13156.</mixed-citation><mixed-citation xml:lang="en">Gonçalves S.E.A.B., Gonçalves T.J.M., Guarnieri A. et al. Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS-CoV-2. J. Diabetes. 2021; 13 (5): 413–419. DOI: 10.1111/1753-0407.13156.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Li W., Li K., Zhang N. et al. [Differential diagnosis of high altitude pulmonary edema and COVID-19 with computed tomography feature]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020; 37 (6): 1031–1036. DOI: 10.7507/1001-5515.202007043 (in Chinese).</mixed-citation><mixed-citation xml:lang="en">Li W., Li K., Zhang N. et al. [Differential diagnosis of high altitude pulmonary edema and COVID-19 with computed tomography feature]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020; 37 (6): 1031–1036. DOI: 10.7507/1001-5515.202007043 (in Chinese).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Maggiorini M. [Prevention and therapy of altitude sickness]. Ther. Umsch. 1993; 50 (4): 221–227 (in German).</mixed-citation><mixed-citation xml:lang="en">Maggiorini M. [Prevention and therapy of altitude sickness]. Ther. Umsch. 1993; 50 (4): 221–227 (in German).</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Schöni M.H. [Inhibition of renal carbonic anhydrase as a respiratory stimulant – an obsolete indication?] Ther. Umsch. 2000; 57 (6): 351–354. DOI: 10.1024/0040-5930.57.6.351 (in German).</mixed-citation><mixed-citation xml:lang="en">Schöni M.H. [Inhibition of renal carbonic anhydrase as a respiratory stimulant – an obsolete indication?] Ther. Umsch. 2000; 57 (6): 351–354. DOI: 10.1024/0040-5930.57.6.351 (in German).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Williams M.H. Vitamin supplementation and athletic performance. Int. J. Vitam. Nutr. Res. Suppl. 1989; 30: 163–191.</mixed-citation><mixed-citation xml:lang="en">Williams M.H. Vitamin supplementation and athletic performance. Int. J. Vitam. Nutr. Res. Suppl. 1989; 30: 163–191.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Harris S.C., Ivy A.C., Friedemann T.E. Work at high altitude; the effect of training and dietary restriction of thiamin and riboflavin on altitude tolerance and physical efficiency for work at a simulated altitude of 15,000 feet. Q. Bull. Northwest Univ. Med. Sch. 1947 Summer; 21 (2): 135–151.</mixed-citation><mixed-citation xml:lang="en">Harris S.C., Ivy A.C., Friedemann T.E. Work at high altitude; the effect of training and dietary restriction of thiamin and riboflavin on altitude tolerance and physical efficiency for work at a simulated altitude of 15,000 feet. Q. Bull. Northwest Univ. Med. Sch. 1947 Summer; 21 (2): 135–151.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Özdemir Z.Ö., Şentürk M., Ekinci D. Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules. J. Enzyme Inhib. Med. Chem. 2013; 28 (2): 316–319. DOI: 10.3109/14756366.2011.637200.</mixed-citation><mixed-citation xml:lang="en">Özdemir Z.Ö., Şentürk M., Ekinci D. Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules. J. Enzyme Inhib. Med. Chem. 2013; 28 (2): 316–319. DOI: 10.3109/14756366.2011.637200.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">McPeake J.M., Shaw M., O'Neill A. et al. Do alcohol use disorders impact on long term outcomes from intensive care? Crit. Care. 2015; 19 (1): 185. DOI: 10.1186/s13054-015-0909-6.</mixed-citation><mixed-citation xml:lang="en">McPeake J.M., Shaw M., O'Neill A. et al. Do alcohol use disorders impact on long term outcomes from intensive care? Crit. Care. 2015; 19 (1): 185. DOI: 10.1186/s13054-015-0909-6.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lima L.F., Leite H.P., Taddei J.A. Low blood thiamine concentrations in children upon admission to the intensive care unit: risk factors and prognostic significance. Am. J. Clin. Nutr. 2011; 93 (1): 57–61. DOI: 10.3945/ajcn.2009.29078.</mixed-citation><mixed-citation xml:lang="en">Lima L.F., Leite H.P., Taddei J.A. Low blood thiamine concentrations in children upon admission to the intensive care unit: risk factors and prognostic significance. Am. J. Clin. Nutr. 2011; 93 (1): 57–61. DOI: 10.3945/ajcn.2009.29078.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Woolum J.A., Abner E.L., Kelly A. et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit. Care Med. 2018; 46 (11): 1747–1752. DOI: 10.1097/CCM.0000000000003311.</mixed-citation><mixed-citation xml:lang="en">Woolum J.A., Abner E.L., Kelly A. et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit. Care Med. 2018; 46 (11): 1747–1752. DOI: 10.1097/CCM.0000000000003311.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Byerly S., Parreco J.P., Soe-Lin H. et al. Vitamin C and thiamine are associated with lower mortality in sepsis. J. Trauma Acute Care Surg. 2020; 89 (1): 111–117. DOI: 10.1097/TA.0000000000002613.</mixed-citation><mixed-citation xml:lang="en">Byerly S., Parreco J.P., Soe-Lin H. et al. Vitamin C and thiamine are associated with lower mortality in sepsis. J. Trauma Acute Care Surg. 2020; 89 (1): 111–117. DOI: 10.1097/TA.0000000000002613.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Marik P.E., Khangoora V., Rivera R. et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017; 151 (6): 1229–1238. DOI: 10.1016/j.chest.2016.11.036.</mixed-citation><mixed-citation xml:lang="en">Marik P.E., Khangoora V., Rivera R. et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017; 151 (6): 1229–1238. DOI: 10.1016/j.chest.2016.11.036.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Derin S., Koseoglu S., Sahin C., Sahan M. Effect of vitamin B12 deficiency on olfactory function. Int. Forum Allergy Rhinol. 2016; 6 (10): 1051–1055. DOI: 10.1002/alr.21790.</mixed-citation><mixed-citation xml:lang="en">Derin S., Koseoglu S., Sahin C., Sahan M. Effect of vitamin B12  deficiency on olfactory function. Int. Forum Allergy Rhinol. 2016; 6 (10): 1051–1055. DOI: 10.1002/alr.21790.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Семенов В.А. и др. О прямых и косвенных неврологических проявлениях COVID-19. Журнал неврологии и психиатрии им. С.С.Корсакова. 2020; 120 (11): 11–21. DOI: 10.17116/jnevro202012011111.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Semenov V.A. et al. [Direct and indirect neurological manifestations of COVID-19]. Zhurnal nevrologii i psikhiatrii im. S.S.Korsakova. 2020; 120 (11): 11–21. DOI: 10.17116/jnevro202012011111 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Zaric D., Christiansen C., Pace N.L., Punjasawadwong Y. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst. Rev. 2003; (2): CD003006. DOI: 10.1002/14651858.CD003006.</mixed-citation><mixed-citation xml:lang="en">Zaric D., Christiansen C., Pace N.L., Punjasawadwong Y. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst. Rev. 2003; (2): CD003006. DOI: 10.1002/14651858.CD003006.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
